Efficacy and safety of Link Natural Sudarshana tablet (an Ayurvedic medicine) against COVID-19 infection – A single center, randomized double-blind, placebo-controlled clinical trial - Trial SLCTR_2021_002
Access comprehensive clinical trial information for SLCTR_2021_002 through Pure Global AI's free database. This Phase 2 trial is sponsored by Link Natural Products (Pvt) Ltd and is currently Completed. The study focuses on COVID-19.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2021_002
Phase 2
Completed
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2021_002
Efficacy and safety of Link Natural Sudarshana tablet (an Ayurvedic medicine) against COVID-19 infection – A single center, randomized double-blind, placebo-controlled clinical trial
Randomized Double-Blind Phase II Clinical Trial to Assess the Efficacy and Safety of an Ayurvedic Formulation, in COVID-19 Infected Patients
Study Focus
Interventional
Sponsor & Location
Link Natural Products (Pvt) Ltd
Sri Lanka
Timeline & Enrollment
Phase 2
Jan 08, 2021
N/A
ICD-10 Classifications
COVID-19, virus identified
COVID-19, virus not identified
Coronavirus infection, unspecified site
Viral infection, unspecified
Rift Valley fever
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2021_002
Non-Device Trial